| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.6M | +26.7% |
| SG&A Expense | $4.2M | -10.6% |
| Operating Income | -$15.8M | -14.0% |
| Pre-tax Income | -$16.1M | -15.9% |
| Income Tax | $0 | — |
| Net Income | -$16.1M | -15.9% |
| EPS (Basic) | -$33.63 | -1660.7% |
| EPS (Diluted) | -$33.63 | -1660.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.0M | -80.5% |
| Total Assets | $3.2M | -79.8% |
| Current Liabilities | $1.9M | +13.2% |
| Total Liabilities | $2.8M | +54.6% |
| Stockholders' Equity | $441K | -96.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.5M | +23.6% |
| Investing Cash Flow | -$21K | +0.0% |
| Financing Cash Flow | $2.2M | +27.0% |